Comparison

InpharmD vs ManageAnticoag

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

InpharmD

Access on-demand digital drug information tailored for healthcare providers. This app promotes evidence-based medicine by saving time and resources.

Highlights
  • On-demand digital drug information
  • Tailored information for providers
  • Promotes evidence-based medicine
  • Saves time and resources
Features
Read full description

We save time and resources for healthcare providers by providing tailored, on demand, digital drug information, in order to promote evidence-based medicine.

About

ManageAnticoag

This clinical decision support tool assists healthcare professionals in managing patients on oral anticoagulants. It provides guidance on interrupting anticoagulation, managing acute bleeds, and restarting treatment. Clinicians can input patient details to receive individualized advice and access supporting information.

Highlights
  • Periprocedural planning for OAC patients
  • Bleed management guidance
  • Anticoagulation interruption and bridging advice
  • Reversal agent suggestions
  • Anticoagulation restart determination
  • Quick Reference section for supporting information
Features
Read full description

This clinical decision support app helps clinicians navigate periprocedural planning and bleed management scenarios for patients on oral anticoagulants (OAC). The app is comprised of three tools to support the following clinical decisions: • Assessing whether and how to interrupt and bridge anticoagulation • Managing acute bleeds, including the suggested use of reversal agents • Determining whether and how anticoagulation should be restarted A clinician can use the app by: • Selecting which tool best applies to the patient scenario and following these steps: o Enter patient details regarding bleed and stroke risk factors as prompted in the selected tool o View individualized guidance on the advice screen o Email a summary of the advice • Use the Quick Reference section to access supporting information and details such as "Guidance for Administering Reversal Agents” and “Components of the Clinician-Patient Discussion." Information in the app is derived from ACC’s Expert Consensus Decision Pathways on Periprocedural Management and Bleed Management in patients with AFib. The information and recommendations in this clinical decision support tool are meant to support clinical decision making. The app is not meant to and should not replace clinical judgement. The healthcare provider is in control of all diagnoses and other clinical decisions.

Screenshots

InpharmD4 screens
ManageAnticoag4 screens

Verdict

The call

InpharmD and ManageAnticoag both sit at 4.9 stars, but that hides the real split: 100% of ManageAnticoag's written reviews are positive against 60% of InpharmD's. ManageAnticoag also leads on ads (none vs shown) and monetization model (free vs free with in-app purchases). InpharmD's advantage is update cadence (every 5 weeks vs every 23 months) and ratings volume (159 vs 7). On price, rating, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 4.9 for InpharmD against 4.9 for ManageAnticoag. That said, the two scores are not equally well evidenced: InpharmD has 159 ratings behind it against 7, so its average is the more settled of the two. Written reviews are what separate them: 60% of InpharmD's written reviews are positive against 100% of ManageAnticoag's.

UpkeepUpdate frequency

InpharmD ships an update every 5 weeks, ManageAnticoag every 23 months. The most recent releases landed on October 23, 2026 and October 26, 2026 respectively.

Scorecard6 real differences · 4 level
InpharmD versus ManageAnticoag: the parameters behind the verdict, then further details
ParameterInpharmDManageAnticoag
PriceFreeFree
Rating4.9 (159 ratings) — better4.9 (7 ratings)
Positive reviews60.0% of reviews100.0% of reviews — better
Number of ratings159 — better7
Update frequencyEvery 5 weeks — betterEvery 23 months
AdsYesNo — better
In-app purchasesNoNo
MonetizationFree with in-app purchasesFree — better
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS18.013.0 — better
Further details — not scored
Size47 MB34 MB
Age rating17+17+
DeveloperInpharmD, LLCAmerican College of Cardiology

Customer experience

InpharmD

All ratings159 ratings
Positive98.7%
Neutral0.0%
Negative1.3%
Written reviews5 reviews
Positive60.0%
Neutral0.0%
Negative40.0%

ManageAnticoag

All ratings7 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews1 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

InpharmD

No in-app purchases

None

ManageAnticoag

No in-app purchases

Questions

Is InpharmD free?
InpharmD is free to download, with no in-app purchases.
Is ManageAnticoag free?
ManageAnticoag is free to download, with no in-app purchases.
Which has better reviews, InpharmD or ManageAnticoag?
InpharmD is rated higher. InpharmD averages 4.9 out of 5 from 159 ratings, while ManageAnticoag averages 4.9 from 7 ratings.
Do InpharmD or ManageAnticoag have ads?
InpharmD shows ads; ManageAnticoag does not.
Which is updated more often, InpharmD or ManageAnticoag?
InpharmD ships an update every 5 weeks, and ManageAnticoag every 23 months. Most recently, InpharmD was updated on October 23, 2026 and ManageAnticoag on October 26, 2026.

Other comparisons